Works matching IS 17355362 AND DT 2024 AND VI 19 AND IP 5


Results: 10
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Efficacy, safety, and immunogenicity of recombinant insulin aspart (BioGenomics Limited) and NovoRapid<sup>®</sup> (Novo Nordisk) in adults with type 2 diabetes mellitus: a randomized, open-label, multicenter, phase-3 study.

    Published in:
    Research in Pharmaceutical Sciences, 2024, v. 19, n. 5, p. 488, doi. 10.4103/RPS.RPS_188_23
    By:
    • Dongre, Sneha A.;
    • Kulkarni, Gauri A.;
    • Mishra, Akshay;
    • Deshmane, Rutuja B.;
    • Sonar, Nameeta;
    • Yashi, Kanica;
    • Thapa, Damodar;
    • Ghade, Nikhil;
    • Kadoo, Sachin M.;
    • Krishnan, Archana R.;
    • Sonar, Sanjay M.
    Publication type:
    Article